Detalhe da pesquisa
1.
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma.
Future Oncol
; : 1-10, 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38861311
2.
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation.
Cancer
; 129(3): 405-414, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36451343
3.
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience.
Cancer Immunol Immunother
; 71(5): 1093-1101, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34568975
4.
Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study.
Clin Oral Investig
; 26(8): 5503-5514, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35556175
5.
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Cancer
; 126(20): 4521-4531, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32749686
6.
Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
Br J Cancer
; 122(11): 1649-1660, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32235905
7.
Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
Br J Cancer
; 123(6): 1041, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32572173
8.
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.
Br J Cancer
; 123(12): 1720-1729, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32963347
9.
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
BMC Cancer
; 20(1): 316, 2020 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32293356
10.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Lancet Oncol
; 20(12): 1681-1690, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31587882
11.
Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study.
J Gastroenterol Hepatol
; 34(4): 747-754, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30345539
12.
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response.
Ther Adv Med Oncol
; 16: 17588359241254218, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38779033
13.
Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma.
Cancer Res Treat
; 56(1): 115-124, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37641819
14.
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer.
Ther Adv Med Oncol
; 16: 17588359241240657, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38523846
15.
Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study.
Cancer Lett
; 596: 216998, 2024 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38830470
16.
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes.
J Immunother Cancer
; 12(6)2024 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38857913
17.
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis.
Transl Lung Cancer Res
; 13(4): 861-874, 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38736501
18.
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Clin Cancer Res
; 30(8): 1582-1594, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38330145
19.
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
J Clin Oncol
; 42(5): 507-517, 2024 Feb 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37699162
20.
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
J Clin Oncol
; 42(3): 324-335, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37976444